BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

496 related articles for article (PubMed ID: 10891409)

  • 1. Protective immunity against feline immunodeficiency virus induced by inoculation with vif-deleted proviral DNA.
    Lockridge KM; Chien M; Dean GA; Stefano Cole K; Montelaro RC; Luciw PA; Sparger EE
    Virology; 2000 Jul; 273(1):67-79. PubMed ID: 10891409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection of cats by injection with DNA of a feline immunodeficiency virus molecular clone.
    Sparger EE; Louie H; Ziomeck AM; Luciw PA
    Virology; 1997 Nov; 238(1):157-60. PubMed ID: 9375019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination of cats with attenuated feline immunodeficiency virus proviral DNA vaccine expressing gamma interferon.
    Gupta S; Leutenegger CM; Dean GA; Steckbeck JD; Cole KS; Sparger EE
    J Virol; 2007 Jan; 81(2):465-73. PubMed ID: 17079309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-existing immunity to pathogenic Listeria monocytogenes does not prevent induction of immune responses to feline immunodeficiency virus by a novel recombinant Listeria monocytogenes vaccine.
    Stevens R; Lavoy A; Nordone S; Burkhard M; Dean GA
    Vaccine; 2005 Feb; 23(12):1479-90. PubMed ID: 15670884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The feline immunodeficiency virus vif gene is required for productive infection of feline peripheral blood mononuclear cells and monocyte-derived macrophages.
    Lockridge KM; Himathongkham S; Sawai ET; Chienand M; Sparger EE
    Virology; 1999 Aug; 261(1):25-30. PubMed ID: 10441553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of gag- and env-specific cytotoxic T lymphocytes in protective immunity to feline immunodeficiency virus.
    Flynn JN; Beatty JA; Cannon CA; Stephens EB; Hosie MJ; Neil JC; Jarrett O
    AIDS Res Hum Retroviruses; 1995 Sep; 11(9):1107-13. PubMed ID: 8554908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Env-specific CTL predominate in cats protected from feline immunodeficiency virus infection by vaccination.
    Flynn JN; Keating P; Hosie MJ; Mackett M; Stephens EB; Beatty JA; Neil JC; Jarrett O
    J Immunol; 1996 Oct; 157(8):3658-65. PubMed ID: 8871667
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with vif-deleted feline immunodeficiency virus provirus, GM-CSF, and TNF-alpha plasmids preserves global CD4 T lymphocyte function after challenge with FIV.
    Maksaereekul S; Dubie RA; Shen X; Kieu H; Dean GA; Sparger EE
    Vaccine; 2009 Jun; 27(28):3754-65. PubMed ID: 19464559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in feline immunodeficiency virus host cell range correlate with envelope fusogenic properties.
    Pancino G; Castelot S; Sonigo P
    Virology; 1995 Feb; 206(2):796-806. PubMed ID: 7856093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gag-specific immune enhancement of lentiviral infection after vaccination with an adenoviral vector in an animal model of AIDS.
    Klonjkowski B; Klein D; Galea S; Gavard F; Monteil M; Duarte L; Fournier A; Sayon S; Górna K; Ertl R; Cordonnier N; Sonigo P; Eloit M; Richardson J
    Vaccine; 2009 Feb; 27(6):928-39. PubMed ID: 19070641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infection of cats with molecularly cloned and biological isolates of the feline immunodeficiency virus.
    Sparger EE; Beebe AM; Dua N; Himathongkam S; Elder JH; Torten M; Higgins J
    Virology; 1994 Dec; 205(2):546-53. PubMed ID: 7975256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA vaccination affords significant protection against feline immunodeficiency virus infection without inducing detectable antiviral antibodies.
    Hosie MJ; Flynn JN; Rigby MA; Cannon C; Dunsford T; Mackay NA; Argyle D; Willett BJ; Miyazawa T; Onions DE; Jarrett O; Neil JC
    J Virol; 1998 Sep; 72(9):7310-9. PubMed ID: 9696827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection against FIV challenge infection by genetic vaccination using minimalistic DNA constructs for FIV env gene and feline IL-12 expression.
    Boretti FS; Leutenegger CM; Mislin C; Hofmann-Lehmann R; König S; Schroff M; Junghans C; Fehr D; Huettner SW; Habel A; Flynn JN; Aubert A; Pedersen NC; Wittig B; Lutz H
    AIDS; 2000 Aug; 14(12):1749-57. PubMed ID: 10985311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of neonatal kittens against feline immunodeficiency virus infection with passive maternal antiviral antibodies.
    Pu R; Okada S; Little ER; Xu B; Stoffs WV; Yamamoto JK
    AIDS; 1995 Mar; 9(3):235-42. PubMed ID: 7755911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual-subtype vaccine (Fel-O-Vax FIV) protects cats against contact challenge with heterologous subtype B FIV infected cats.
    Kusuhara H; Hohdatsu T; Okumura M; Sato K; Suzuki Y; Motokawa K; Gemma T; Watanabe R; Huang C; Arai S; Koyama H
    Vet Microbiol; 2005 Jul; 108(3-4):155-65. PubMed ID: 15899558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative efficiency of feline immunodeficiency virus infection by DNA inoculation.
    Rigby MA; Hosie MJ; Willett BJ; Mackay N; McDonald M; Cannon C; Dunsford T; Jarrett O; Neil JC
    AIDS Res Hum Retroviruses; 1997 Mar; 13(5):405-12. PubMed ID: 9075482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccination using expression vectors carrying FIV structural genes induces immune response against feline immunodeficiency virus.
    Cuisinier AM; Mallet V; Meyer A; Caldora C; Aubert A
    Vaccine; 1997 Jul; 15(10):1085-94. PubMed ID: 9269051
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoptive immunotherapy of feline immunodeficiency virus with autologous ex vivo-stimulated lymphoid cells modulates virus and T-cell subsets in blood.
    Flynn JN; Pistello M; Isola P; Zaccaro L; Del Santo B; Ricci E; Matteucci D; Bendinelli M
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):736-45. PubMed ID: 15939748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual-subtype feline immunodeficiency virus vaccine provides 12 months of protective immunity against heterologous challenge.
    Huang C; Conlee D; Gill M; Chu HJ
    J Feline Med Surg; 2010 Jun; 12(6):451-7. PubMed ID: 20167521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A feline immunodeficiency virus vif-deletion mutant remains attenuated upon infection of newborn kittens.
    Shen X; Leutenegger CM; Stefano Cole K; Pedersen NC; Sparger EE
    J Gen Virol; 2007 Oct; 88(Pt 10):2793-2799. PubMed ID: 17872533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.